BrainsWay Ltd.
NASDAQ:BWAYMedical - Devices
+$0.05 today
- Market cap
- $352.22M
- Beta
- 0.15
- P/E (TTM)
- 61.7
- EPS (TTM)
- $0.23
Volume 0.15M
Average 0.15M
BWAY Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
BrainsWay Ltd.NASDAQ: BWAY
Financing Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Financing cash flow growth accelerates
Q1 FY2026 financing cash flow of $901K (cash outflow) rose 19.3% year over year, ahead of the -113.1% change in trailing-twelve-month financing cash flow. Sequentially, it fell 9.5% from the prior quarter. Over 3 fiscal years it compounded at +13.0% a year.
Context
- Financing cash flow amounted to 4.3% of revenue in FY2025, down 40.3 pp from a year earlier.
- Financing cash flow increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +19.3% holds above the trailing-twelve-month pace of -113.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (2.23M) USD
- Year-over-year change
- -112.2%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (2.23M) | -112.2% |
| FY2024 | 2024-12-31 | 18.26M | +1880.0% |
| FY2023 | 2023-12-31 | (1.03M) | +33.7% |
| FY2022 | 2022-12-31 | (1.55M) | -103.7% |
| FY2021 | 2021-12-31 | 41.52M | — |
Financing Cash Flow vs competitors
How BWAY compares with its peers on the latest reported figures
- BWAY's LTM Mar 2026 financing cash flow of $2.37M is the 3rd largest of the 4 companies compared; the peer median is $11.3M.
- Its year-over-year change of -113.1% is the lowest of 4, against a peer median of -7.2%.
- Financing cash flow amounts to 4.2% of revenue for BWAY, versus a peer median of 7.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $442.16M | +4786.8% | +192.9% | 4611.1% | |
| LTM Mar 2026 | $11.3M | -7.2% | +457.4% | 7.4% | |
| LTM Mar 2026 | $2.37M | -113.1% | +13.0% | 4.2% | |
| LTM Mar 2026 | $1.67M | -106.6% | +242.0% | 1.7% | |
MOBIMobia Medical, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding BWAY) | $11.3M | -7.2% | +242.0% | 7.4% | |
Competitors are the stored peer set for BWAY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (6.46M) | (13.35M) | (4.2M) | 2.92M | 7.63M |
| Depreciation & Amortization | 1.69M | 1.53M | 1.34M | 1.77M | 1.54M |
| Deferred Income Tax | 43K | 315K | 251K | 538K | 77K |
| Stock-Based Compensation | 1.89M | 1.47M | 381K | 1.44M | 1.2M |
| Change in Working Capital | 1.07M | (1.45M) | 1.64M | 2.39M | 8.23M |
| Accounts Receivables | (849K) | 1.46M | 1.09M | (867K) | 611.82K |
| Inventory | (411K) | (3.6M) | (506K) | (920K) | (1.41M) |
| Accounts Payables | 289K | 0 | (327K) | 2.12M | (480.78K) |
| Other Working Capital | 2.04M | 685K | 1.38M | 2.06M | 9.52M |
| Other Non-Cash Items | 2.66M | 1.72M | 1.88M | 1.24M | (506.79K) |
| Operating Cash Flow | 884K | (9.76M) | 1.28M | 10.3M | 18.16M |
| Capital Expenditures | (2.24M) | 9.72M | (2.39M) | (3.79M) | (1.76M) |
| Acquisitions (Net) | 39.98M | 0 | 0 | 0 | 0 |
| Purchases of Investments | (40M) | (21K) | 0 | 0 | (15.89M) |
| Sales of Investments | 22K | 40.25M | 0 | 0 | 20.16K |
| Other Investing Activities | (39.98M) | 0 | (35.02M) | 35.08M | 0 |
| Investing Cash Flow | (42.22M) | 42.17M | (37.41M) | 30.31M | (17.63M) |
| Debt Repayment | (475K) | (533K) | (271K) | (424K) | (832K) |
| Common Stock Issued | 42.26M | 0 | 0 | 16.35M | 0 |
| Common Stock Repurchased | 0 | (52K) | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (269K) | (962K) | (755K) | 2.33M | (1.4M) |
| Financing Cash Flow | 41.52M | (1.55M) | (1.03M) | 18.26M | (2.23M) |
| Effect of Forex Changes | (224K) | (202K) | 90K | (47K) | 34.35K |
| Net Change in Cash | (40K) | 30.66M | (37.06M) | 58.83M | (1.67M) |
| Free Cash Flow | (1.35M) | (9.76M) | (1.1M) | 6.5M | 16.4M |
BrainsWay Ltd.
NASDAQ:BWAY
Intrinsic Alpha fair value
Locked
Current Price
$8.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.